{"name":"Health Ever Bio-Tech Co., Ltd.","slug":"health-ever-bio-tech-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"MCS-2","genericName":"MCS-2","slug":"mcs-2","indication":"Type 2 diabetes","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"MCS","genericName":"MCS","slug":"mcs","indication":"Atrial fibrillation for stroke prevention","status":"phase_3"}]}],"pipeline":[{"name":"MCS-2","genericName":"MCS-2","slug":"mcs-2","phase":"phase_3","mechanism":"MCS-2 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"MCS","genericName":"MCS","slug":"mcs","phase":"phase_3","mechanism":"MCS is a small molecule that targets the molecular target.","indications":["Atrial fibrillation for stroke prevention"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSDBXZ243SnRELU9tTG5VZTBBaUFIQkVwVmJEYW42OGc5emVxOWVhSGlZcng5U1RDZE5IWUM5YUdYRE1VSDBpVFZxTW5iNUF0X29DSUlDa3RBaHpKRmhwODNuU1hlRmEyQzNDLU9VUlVYN29vb3dTZFl1T21FU2FWNXpGZklzS2hZQXNoV21KczXSAZYBQVVfeXFMTmdVSG5xdU5Qa2JKdFpoQWYyaHhkUkxfM1FUdmljWjc5Z2VZYkxxRzhsa0VmZWZXc2h1UWY4MFFibXlwbXplT0VBS2dITk5ya1oxVlRwN3JJUF9fOFkwQlZ5eHB1NmNwRWZQV0NvMVlmSDZka3laZlZTMjNaN1FXdWxiU0hUSC1XckpWb09qRGNVSDI3UXdR?oc=5","date":"2026-01-17","type":"pipeline","source":"BioInformant","summary":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant","headline":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPRTUwT204dkVPUi1CTkNUYTNpQTRQZEVJdmtMaW10amdnQjJ2MUhxRm9pX0JuM01ZUU9EcG9MRzNfTm9XY0xMcmJCZHRxWkg2T1o0azMwcFRsTmRXN0pKNS15UWRkYkd6MzVsMURpN25LS1paU1luT2hrTXpIaklQTkdDSzc5Tm5lS3piNHVFVm81a05ySEpJQQ?oc=5","date":"2026-01-16","type":"pipeline","source":"The Motley Fool UK","summary":"Investing in Biotech: Top UK Biotech Stocks of 2026 - The Motley Fool UK","headline":"Investing in Biotech: Top UK Biotech Stocks of 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE93dERKNFJ6Y2dsWHk3SktVVW9ZYUVUVUt2MFVTbnRuTDJBeDVyR2dHTUd1dVQ5QVkyUElieE9jWXo5d1U1WFVvTXkxbkpGb3BaalVVNjhMWV9lWmpwTi1IaU1GU0NZMzVuX3VRTUVzQW40ZFNxVTRCUGRqQ29WdHM?oc=5","date":"2026-01-08","type":"deal","source":"Yahoo Finance","summary":"During J. P. Morgan Healthcare Week, Biotech Showcase™ Provides Private and Micro- to Mid-Cap Public Company Executives One-Stop Access to Investors, Pharma Partners and Media - Yahoo Finance","headline":"During J. P. Morgan Healthcare Week, Biotech Showcase™ Provides Private and Micro- to Mid-Cap Public Company Executives ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOQkxmbk12TjRSRXhEVnFZTGotcy1sUlZsYXdPSTNBeV9BTk40QnJraDBzeHppNGpuR0JLVmk3TV82a0drdXhTdUpGOTgzMk5DbVdlclZYMTQzSzlfelE1eTdwYXpGVXBNMzV6eW05ZjBPLTFTMHF5TUNscEVlTkhqWQ?oc=5","date":"2025-12-19","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds - Fierce Biotech","headline":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPQ0IyRmpWZzhoSnhlMVFEdVdtRzM2TjRtN0FfSXp5YjBSMHJVcGZwNlJxR09OODhWQWhIM3NRcV9pdEczQUhiaEs1aXpXYVlRWFlWb1k5QVVfd0t5bmQxRmVGblpDZVM4SmRtN2taaExmRU9KN3BmLU95bVRRM1V4aWtYaEZQVGpZNzRsOEVrSTdVc2FiVTFDcDJhb19DczA5M2IzM0FR?oc=5","date":"2025-12-09","type":"pipeline","source":"BioWorld News","summary":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025 - BioWorld News","headline":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxPNWcwMTFEUmJqWE4wRGpBSVFPcHFhcW41Z2dHWTV3OXNRSkcyVEtnQzg2WFVpdFFnN0lKbjZfUUg2SnN3YVpIN2tEXzM3SDJKVFBvWUpSQkFzdlJaekJKelFwcGo1MGZqUXVCTkEzamR0dFNuNHFFLWFRRnRWVjRIaERSTEtnc2JxVVA0UnZpRVI4emp5d05CVkR5TWNyXzJvazlFeHNaa3VNUHhfNkwwcWw4RXo4dEVXcEU1cGlVUGJEQlVHQ1d5OVlB?oc=5","date":"2025-11-06","type":"pipeline","source":"AFR","summary":"CSL’s crisis explained: How to lose $55b and alienate investors - AFR","headline":"CSL’s crisis explained: How to lose $55b and alienate investors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxOWi1mY3E1LXBUaC1XMURMYl9uOWg3dFRtZjJDWDlhZXIzbFpaS1FETjdETHlXdW9mbEd0SlpNb0ViN2M1LUdRbzdCSWRkYkhiYzB4VjBDbnp5ZlZZTElMcUNSMG12Sk5RMEFmTGRKelVRNUttQmZnSU5xaXE4Q1RvalZVRzNnQQ?oc=5","date":"2025-10-28","type":"pipeline","source":"Labiotech.eu","summary":"10 biotech companies in China you should know about - Labiotech.eu","headline":"10 biotech companies in China you should know about","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9RM0ZUb1lENTZ0RlpORlZtRGh4Yy1YUm12Z0REaVM2VUtQMkpqLUJBanZJcDBXN3dKYzRpcjdIV1pPbUNKQkdmMjhRbktxOFlxckRhSm85SnpHMlpOODd4MllPOXJyYWJ4OWRqWDBB?oc=5","date":"2025-10-28","type":"pipeline","source":"KED Global","summary":"Maryland to launch $100 mn fund, 1st US state venture targeting Korean biotech - KED Global","headline":"Maryland to launch $100 mn fund, 1st US state venture targeting Korean biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQa0N6MGhoUjV1N0h3MVdtTGlNQWRQMF9YV0hERmNqMXlBM0pySXlJcUhST1A2WmtXc0dTNWQ0QkxSTXUzZm80YUZ3WW1zUVJ0UDBjMlNpODVYME1nTmlDSjN4TC04VDdWUHdwX05oY0htSmdQZWI0bDNwUGMzNXlMY19acUZwWTJ1TFhCZDQxZHNjbUdpUHlncm93LTFyTmlG?oc=5","date":"2025-10-16","type":"pipeline","source":"the-scientist.com","summary":"Top Reasons Biotech Financing Falls Through—and How to Fix Them - the-scientist.com","headline":"Top Reasons Biotech Financing Falls Through—and How to Fix Them - the","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxNWG4zbm9ZM2ZwcGNoSHU5WHFuaUJzNVM2X0JiMFRlRlVMZUNXWWJpajFFVlJURl9meEhKOXBQTDAyQXNGeGk0NEJzX0plX0dFY2pTa2JyN1EtWmxyVG1zc2lKQ2g0TEMwdlZHSGFmbGJLU3dDcUJ0U25qcFkwNFY3elVBMWhkXzlqUmhqNWJCLTY4T0ZxRFd6di1DT1BneV9RM3FHdy1mUms3eElaT0FKSUlwTWdieXFDNDM1NUNTRlpKZDZvaXNsLU4zQ3pVcjZ5RmFKYk5vOA?oc=5","date":"2025-10-14","type":"deal","source":"Reuters","summary":"US biotech Nabla Bio, Japan's Takeda expand AI drug design partnership - Reuters","headline":"US biotech Nabla Bio, Japan's Takeda expand AI drug design partnership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPaWhCM29CTnRCNWhrYThFY2xyWVpNMTQzM1NTN3ZWcEpGR1dXSmFXc1podVNnTi1aX1doYkhIMnJ3ZlRkaHJLUDNVZlJ4ZEswa1Q3LVNFaDhMam1GQ2hrV1NtWVZKSmtqcFdTeDctd3F3dGFrZ3FBM3lseXo4ZU0xXzkyeWdXQzFvN2VhRmdlR1VSaTc4bmwyaW9sNnpSTVU3MU50Yy00T0liYU0t?oc=5","date":"2025-07-26","type":"regulatory","source":"Seeking Alpha","summary":"Jyong Biotech Stock: Plant‑Based Pipeline Targets Huge Markets Risks Remain (NASDAQ:MENS) - Seeking Alpha","headline":"Jyong Biotech Stock: Plant‑Based Pipeline Targets Huge Markets Risks Remain (NASDAQ:MENS)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPQm5Bb2ZDM2VWb0hRY3VGOWFSekdBV25HVUhFVk83YzBsZlQ2VHl4T1NKS1RpcjR4T2dDUl9rOXBwaTZ6dkZJSWkzUmZTZjZNVEdwRDZOWlBLU1BQdmJzSEVkb2V4emFVTGwyUFIxOEV2emwyQUN5SlBSQ01HRVBReTRwdzR1dm5oZUZQQTNFQ3dBcGJfX1ZpV2hZYlpkdFhWZG5MSm5jV1RhcS1KVUNXRExXYXQ1SkdWX2gzbi0wMDZEZTA?oc=5","date":"2025-07-13","type":"pipeline","source":"Bloomberg.com","summary":"China Biotech’s Stunning Advance Is Changing the World’s Drug Pipeline - Bloomberg.com","headline":"China Biotech’s Stunning Advance Is Changing the World’s Drug Pipeline","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}